Answers are grounded in this paper and cite their sources.
Results from this study suggest composite biomarkers created from multiparametric MR-PET imaging targeting metabolic and/or physiologic processes specific to the drug mechanism of action may be useful for subsequent evaluation of treatment efficacy for larger phase II-III studies.
No takes yet. Share an insight, caveat, or question.
Ellingson et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: